SC 13G: Oncocyte Corp
Ticker: IMDX · Form: SC 13G · Filed: Apr 22, 2024 · CIK: 1642380
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Oncocyte Corp.
Risk Assessment
Risk Level: low
Filing Stats: 716 words · 3 min read · ~2 pages · Grade level 13.8 · Accepted 2024-04-22 13:30:07
Filing Documents
- formsc13gapril2024.htm (SC 13G) — 58KB
- 0000012208-24-000027.txt ( ) — 60KB
Not applicable
Item 3. Not applicable
Ownership
Item 4. Ownership (a) Amount beneficially owned 1,200,109 Common Shares (b) Percent of class 8.99 % (c) Number of shares as to which the person has (i) Sole power to vote or to direct the vote 1,200,109 Common Shares (ii) Shared power to vote or to direct the vote 0 Common Shares (iii) Sole power to dispose or to direct the disposition of 1,200,109 Common Shares (iv) Shared power to dispose or to direct the disposition of 0 Common Shares
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following Page 2
Ownership of More than Five Percent on Behalf of Another Person
Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person Not applicable
Identification and Classification of Members of the Group
Item 8. Identification and Classification of Members of the Group Not applicable
Notice of Dissolution of Group
Item 9. Notice of Dissolution of Group Not applicable
Certifications
Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 3
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. BIO-RAD LABORATORIES INC. Date April 22, 2024 By s Norman Schwartz Name Norman Schwartz Title President and Chief Executive Officer Page 4